ACADM
Medium-chain specific acyl-CoA dehydrogenase, mitochondrial
Also known as: ACAD1, ACADM_HUMAN, MCAD, MCADH
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P11310
- Gene
- ACADM
- Ensembl
- ENSG00000117054
- Chromosome
- 1
- Canonical length
- 421 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Mitochondria,Calyx,Principal piece
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
This gene encodes the medium-chain specific (C4 to C12 straight chain) acyl-Coenzyme A dehydrogenase. The homotetramer enzyme catalyzes the initial step of the mitochondrial fatty acid beta-oxidation pathway. Defects in this gene cause medium-chain acyl-CoA dehydrogenase deficiency, a disease characterized by hepatic dysfunction, fasting hypoglycemia, and encephalopathy, which can result in infantile death. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
421 residues, UniProt reviewed canonical sequence.
>P11310|ACADM
1 MAAGFGRCCR VLRSISRFHW RSQHTKANRQ REPGLGFSFE FTEQQKEFQA TARKFAREEI
61 IPVAAEYDKT GEYPVPLIRR AWELGLMNTH IPENCGGLGL GTFDACLISE ELAYGCTGVQ
121 TAIEGNSLGQ MPIIIAGNDQ QKKKYLGRMT EEPLMCAYCV TEPGAGSDVA GIKTKAEKKG
181 DEYIINGQKM WITNGGKANW YFLLARSDPD PKAPANKAFT GFIVEADTPG IQIGRKELNM
241 GQRCSDTRGI VFEDVKVPKE NVLIGDGAGF KVAMGAFDKT RPVVAAGAVG LAQRALDEAT
301 KYALERKTFG KLLVEHQAIS FMLAEMAMKV ELARMSYQRA AWEVDSGRRN TYYASIAKAF
361 AGDIANQLAT DAVQILGGNG FNTEYPVEKL MRDAKIYQIY EGTSQIQRLI VAREHIDKYK
421 NLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ACADM can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 446 nTPM
Expression across tissuesHPA
Tissue
- tongue: 446 nTPM
- skeletal muscle: 357 nTPM
- liver: 344 nTPM
- kidney: 277 nTPM
- heart muscle: 204 nTPM
- duodenum: 98 nTPM
Single-cell type
- esophageal apical cells: 740 nCPM
- hepatocytes: 338 nCPM
- parietal cells: 317 nCPM
- myonuclei: 247 nCPM
- proximal tubule cells: 108 nCPM
- enterocytes: 108 nCPM
Immune cell
- memory B-cell: 41 nTPM
- MAIT T-cell: 27 nTPM
- NK-cell: 25 nTPM
- naive B-cell: 25 nTPM
- naive CD8 T-cell: 24 nTPM
- plasmacytoid DC: 23 nTPM
Brain region
- choroid plexus: 16 nTPM
- midbrain: 6.7 nTPM
- medulla oblongata: 6.6 nTPM
- cerebral cortex: 5.9 nTPM
- cerebellum: 5.5 nTPM
- spinal cord: 4.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ACADM.
Disease | AllUniProt
Conditions ACADM is implicated in, by any mechanism.
- Acyl-CoA dehydrogenase medium-chain deficiency (ACADMD) MIM:201450
Disease | GeneticClinVar
374 pathogenic / likely-pathogenic of 1,075 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Medium-chain acyl-coenzyme A dehydrogenase deficiency
- ACADM-related disorder
- MCADD - Medium-chain acyl-CoA dehydrogenase deficiency – full ACADM sequencing newborn screening follow up
- Inborn genetic diseases
- See cases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.15
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.54
- DepMap mean gene effect
- 0
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cardiac muscle cell differentiation
- carnitine biosynthetic process
- carnitine metabolic process, CoA-linked
- fatty acid beta-oxidation
- fatty acid beta-oxidation using acyl-CoA dehydrogenase
- glycogen biosynthetic process
- liver development
- medium-chain fatty acid catabolic process
- medium-chain fatty acid metabolic process
- post-embryonic development
- regulation of gluconeogenesis
- response to cold
- response to starvation
Molecular functions
- acyl-CoA dehydrogenase activity
- flavin adenine dinucleotide binding
- identical protein binding
- medium-chain fatty acyl-CoA dehydrogenase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Acyl-CoA dehydrogenase, conserved site
- Acyl-CoA dehydrogenase/oxidase, middle domain
- Acyl-CoA dehydrogenase/oxidase, C-terminal
- Acyl-CoA dehydrogenase/oxidase, N-terminal and middle domain superfamily
- Acyl-CoA dehydrogenase/oxidase, N-terminal
- Acyl-CoA dehydrogenase-like, C-terminal
- Acyl-CoA dehydrogenase/oxidase, N-terminal domain superfamily
- Acyl-CoA oxidase/dehydrogenase, middle domain superfamily
- Acyl-CoA dehydrogenase, C-terminal domain
- Acyl-CoA dehydrogenase, middle domain
- Acyl-CoA dehydrogenase, N-terminal domain
- Medium-chain specific acyl-CoA dehydrogenase
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ACADM in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ACADM as an antibody target. Whether an autoantibody or antibody against ACADM could matter depends on whether native ACADM is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ACADM is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ACADM as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...